Clinical features and management of GPRC5D-associated adverse events in novel GPRC5D × CD3 bispecific talquetamab-treated relapsed/refractory multiple myeloma patients: the MonumenTAL-1 China cohort experience
Gang An, Jie Jin, Zhen Cai, Hongmei Jing et autres
0 citationsHematology